Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Varicella zoster virus (VZV)-human neuron interaction.

Baird NL, Yu X, Cohrs RJ, Gilden D.

Viruses. 2013 Sep 4;5(9):2106-15. doi: 10.3390/v5092106. Review.

2.

Varicella zoster virus latency, neurological disease and experimental models: an update.

Cohrs RJ, Gilden DH, Mahalingam R.

Front Biosci. 2004 Jan 1;9:751-62. Review.

PMID:
14766405
3.

A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.

Kennedy PG, Rovnak J, Badani H, Cohrs RJ.

J Gen Virol. 2015 Jul;96(Pt 7):1581-602. doi: 10.1099/vir.0.000128. Review.

4.

Varicella-zoster virus infection of differentiated human neural stem cells.

Pugazhenthi S, Nair S, Velmurugan K, Liang Q, Mahalingam R, Cohrs RJ, Nagel MA, Gilden D.

J Virol. 2011 Jul;85(13):6678-86. doi: 10.1128/JVI.00445-11.

5.

Three-dimensional normal human neural progenitor tissue-like assemblies: a model of persistent varicella-zoster virus infection.

Goodwin TJ, McCarthy M, Osterrieder N, Cohrs RJ, Kaufer BB.

PLoS Pathog. 2013;9(8):e1003512. doi: 10.1371/journal.ppat.1003512.

6.

Review: The neurobiology of varicella zoster virus infection.

Gilden D, Mahalingam R, Nagel MA, Pugazhenthi S, Cohrs RJ.

Neuropathol Appl Neurobiol. 2011 Aug;37(5):441-63. doi: 10.1111/j.1365-2990.2011.01167.x. Review.

7.

Varicella zoster virus infection of highly pure terminally differentiated human neurons.

Yu X, Seitz S, Pointon T, Bowlin JL, Cohrs RJ, Jonjić S, Haas J, Wellish M, Gilden D.

J Neurovirol. 2013 Feb;19(1):75-81. doi: 10.1007/s13365-012-0142-x.

8.

Varicella-zoster virus human ganglionic latency: a current summary.

Kennedy PG, Cohrs RJ.

J Neurovirol. 2010 Nov;16(6):411-8. doi: 10.3109/13550284.2010.515652. Review.

PMID:
20874010
9.

The variegate neurological manifestations of varicella zoster virus infection.

Gilden D, Nagel MA, Cohrs RJ, Mahalingam R.

Curr Neurol Neurosci Rep. 2013 Sep;13(9):374. doi: 10.1007/s11910-013-0374-z. Review.

10.

Latency and reactivation of varicella zoster virus infections.

Dueland AN.

Scand J Infect Dis Suppl. 1996;100:46-50. Review.

PMID:
9163025
11.

Developments in Varicella Zoster Virus Vasculopathy.

Nagel MA, Gilden D.

Curr Neurol Neurosci Rep. 2016 Feb;16(2):12. doi: 10.1007/s11910-015-0614-5. Review.

PMID:
26750127
12.

Clinical and molecular pathogenesis of varicella virus infection.

Gilden DH, Cohrs RJ, Mahalingam R.

Viral Immunol. 2003;16(3):243-58. Review.

PMID:
14583142
13.

Varicella-zoster virus infection of human dorsal root ganglia in vivo.

Zerboni L, Ku CC, Jones CD, Zehnder JL, Arvin AM.

Proc Natl Acad Sci U S A. 2005 May 3;102(18):6490-5.

14.

Varicella Zoster Virus in the Nervous System.

Gilden D, Nagel M, Cohrs R, Mahalingam R, Baird N.

F1000Res. 2015 Nov 26;4. pii: F1000 Faculty Rev-1356. doi: 10.12688/f1000research.7153.1. Review.

15.

VZV infection of keratinocytes: production of cell-free infectious virions in vivo.

Gershon MD, Gershon AA.

Curr Top Microbiol Immunol. 2010;342:173-88. doi: 10.1007/82_2010_13. Review.

PMID:
20225011
16.
17.

Varicella-zoster virus latency in human ganglia.

Kennedy PG.

Rev Med Virol. 2002 Sep-Oct;12(5):327-34. Review.

PMID:
12211045
18.

Molecular and therapeutic aspects of varicella-zoster virus infection.

Quinlivan M, Breuer J.

Expert Rev Mol Med. 2005 Aug 10;7(15):1-24. Review.

PMID:
16098235
19.

Latency of varicella zoster virus; a persistently perplexing state.

Kinchington PR.

Front Biosci. 1999 Feb 15;4:D200-11. Review.

PMID:
9989948
20.

Lessons to be learned from varicella-zoster virus.

Rentier B, Piette J, Baudoux L, Debrus S, Defechereux P, Merville MP, Sadzot-Delvaux C, Schoonbroodt S.

Vet Microbiol. 1996 Nov;53(1-2):55-66. Review.

PMID:
9010998
Items per page

Supplemental Content

Support Center